GSK/IAVI M72 Tuberculosis Vaccine Candidate Phase IIb Trial… SpyDa Nov 2, 2019 GSK/IAVI M72 Tuberculosis Vaccine Candidate Phase IIb Trial Results “We are one more cautious, but exciting,…
